BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37949419)

  • 21. The N6-Methyladenosine Regulator
    Zhao Y; Sun J; Jin L
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.
    Wang X; Huang R; Lu Z; Wang Z; Chen X; Huang D
    Cancer Sci; 2022 Mar; 113(3):986-1001. PubMed ID: 35092121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of 
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of 
Lung Cancer].
    Zhang Y; Wang Y; Liu M
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer.
    An Y; Duan H
    J Ovarian Res; 2024 Apr; 17(1):84. PubMed ID: 38637813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human THP-1 macrophages activated by exosomes derived from lung adenocarcinoma cells promote lung cancer cell invasion].
    Chen L; Yang Y; Huang C; Cao P; Wu Q; Chen S; Chen F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):967-972. PubMed ID: 31878991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.
    Huang S; Jin M; Lan X; Wu JL; Zhang Z; Zhao J; Li Y
    J Cancer; 2022; 13(8):2662-2672. PubMed ID: 35711823
    [No Abstract]   [Full Text] [Related]  

  • 29. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
    Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
    Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Zhao X; Zhao Z; Xie H; Gao W; Ye C
    Discov Med; 2024 Jan; 36(180):61-70. PubMed ID: 38273746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 32. LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.
    Li Y; Chen C; Liu HL; Zhang ZF; Wang CL
    Cell Mol Biol Lett; 2022 Oct; 27(1):91. PubMed ID: 36221069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANKRD22 promotes M2 polarization in lung adenocarcinoma macrophages via the glycolytic pathway.
    Cao J; Zhang H; Wei X; Zhou H
    Chem Biol Drug Des; 2024 Jan; 103(1):e14445. PubMed ID: 38230786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m
    Zhang X; Wang F; Wang Z; Yang X; Yu H; Si S; Lu J; Zhou Z; Lu Q; Wang Z; Yang H
    Ann Transl Med; 2020 May; 8(10):646. PubMed ID: 32566583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
    Hu Z; Zhu L; Zhang Y; Chen B
    Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ELANE Promotes M2 Macrophage Polarization by Down-Regulating PTEN and Participates in the Lung Cancer Progression.
    Song S; Zhao Y; Fu T; Fan Y; Tang J; Wang X; Liu C; Chen X
    Immunol Invest; 2023 Jan; 52(1):20-34. PubMed ID: 36102787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
    Cui X; Nilsson K; Kajitani N; Schwartz S
    Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
    Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
    Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target genes of N6-methyladenosine regulatory protein
    Jiang L; Lan L; Qiu Y; Lu W; Wang W; Huang Y
    J Thorac Dis; 2023 Jun; 15(6):3228-3236. PubMed ID: 37426138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.